The peptide
database

48 compounds, each with the numbers that actually matter — dosing range, half-life, reconstitution volume, storage window, side-effect profile and an honest label on how much human evidence exists. Every injectable one opens in the reconstitution calculator with its own vial size, water volume and dose already loaded.

48 compounds · 10 classes

48 compounds

Fat Loss

5-amino-1-methylquinolinium iodide · 5A1MQ

Oral NNMT inhibitor aimed at fat-cell metabolism and NAD+ salvage. Mouse data only.

Dose
50–150 mg
Frequency
once daily
Half-life
Animal only
Growth Factors

Ramatercept · ActRIIB-Fc

Myostatin and activin decoy receptor; human trials were halted over bleeding side effects.

Dose
1–3 mg
Frequency
Once weekly
Half-life
12.5 days
Early human
Fat Loss

AOD9604 · Tyr-hGH(177-191)

Modified hGH tail fragment sold for lipolysis without the IGF-1 rise of growth hormone.

Dose
250–500 mcg
Frequency
once daily
Half-life
3 min
Human trials
Immune

Cibinetide · pHBSP

EPO-derived peptide targeting the innate repair receptor, trialled for small-fibre neuropathy.

Dose
1–4 mg
Frequency
once daily
Half-life
20 min
Early human
Healing

PL 14736 · PL-10

Gastric-juice-derived pentadecapeptide studied for tendon, ligament and gut healing.

Dose
200–500 mcg
Frequency
1x daily (some split into 2x daily during an acute injury)
Half-life
15 min
Animal only
Fat Loss

AM833 · Cagri

Long-acting amylin analogue run weekly for satiety, usually alongside a GLP-1.

Dose
0.3–4.5 mg
Frequency
once weekly
Half-life
6.6 days
Human trials
Neuro

FPF-1070 · Cerebrolysin concentrate

Porcine brain peptide mixture with the strongest human trial data of any nootropic peptide.

Dose
215–2152 mg
Frequency
Once daily, 5 days per week
Half-life
Human trials
Secretagogues

Mod GRF 1-29 · Modified GRF (1-29)

Short-acting GHRH fragment that sharpens one GH pulse, almost always run with a GHRP.

Dose
50–200 mcg
Frequency
1-3x daily
Half-life
30 min
Animal only
Secretagogues

CJC-1295 DAC · DAC:GRF

Albumin-binding GHRH analogue that lifts GH and IGF-1 for days from one injection.

Dose
500–1000 mcg
Frequency
1-2x weekly
Half-life
7 days
Early human
Neuro

PNB-0408 · N-hexanoyl-Tyr-Ile-aminohexanoic amide

Angiotensin IV analogue promoted for synapse growth; potent in rodents, unproven in humans.

Dose
5–20 mg
Frequency
Once daily, or every other day given the long residence time
Half-life
Animal only
Longevity

Epithalon · Epithalone

Pineal-derived tetrapeptide studied for telomerase activation and circadian regulation.

Dose
5–10 mg
Frequency
Once daily during a course
Half-life
Early human
Growth Factors

FST-344 · FS-344

Activin- and myostatin-binding protein run in short daily courses; data are animal-only.

Dose
50–200 mcg
Frequency
Once daily
Half-life
1 h
Animal only
Healing

Copper tripeptide-1 · Copper peptide

Copper-carrying tripeptide studied for collagen synthesis, wound repair and skin remodelling.

Dose
1–3 mg
Frequency
1x daily
Half-life
Early human
Secretagogues

Pralmorelin · KP-102

Potent, well-studied GHRP with a bigger pulse than ipamorelin and more cortisol.

Dose
100–300 mcg
Frequency
2-3x daily
Half-life
Human trials
Secretagogues

SK&F 110679 · GHRP

The original GHRP: solid GH release and the strongest hunger response of the group.

Dose
100–300 mcg
Frequency
2-3x daily
Half-life
2.5 h
Early human
HPTA

GnRH · LHRH

Native GnRH decapeptide, now the usual compounded stand-in for hCG on TRT.

Dose
100–400 mcg
Frequency
1-2x daily
Half-life
4 min
Human trials
HPTA

HCG · Chorionic Gonadotropin

LH-mimic that keeps the testes producing while exogenous androgens shut the axis down.

Dose
125–4000 IU
Frequency
Every other day, or 2-3x per week
Half-life
23 h
Human trials
Secretagogues

Examorelin · Hex

The most potent GHRP, and the fastest to stop working if you run it continuously.

Dose
50–200 mcg
Frequency
1-2x daily
Half-life
55 min
Early human
GH

Somatropin · rhGH

Recombinant human growth hormone, the reference compound every GH peptide tries to imitate.

Dose
1–6 IU
Frequency
Once daily, split into two injections above about 4 IU
Half-life
3 h
Human trials
Fat Loss

HGH Frag · Frag 176-191

The C-terminal tail of growth hormone, sold for fat loss on almost entirely rodent evidence.

Dose
125–500 mcg
Frequency
Once daily, fasted (many split it into two 250 mcg doses)
Half-life
Animal only
HPTA

HMG · Menotropin

Urine-derived FSH plus LH activity, added to hCG when sperm counts will not recover.

Dose
75–150 IU
Frequency
3x per week
Half-life
Human trials
Longevity

HN · MT-RNR2 peptide

First mitochondrial-derived peptide discovered, studied for cytoprotection and metabolism.

Dose
0.5–2 mg
Frequency
3x per week
Half-life
Animal only
Growth Factors

DES(1-3)IGF-1 · IGF-1 DES(1-3)

Truncated IGF-1 analogue with roughly 10x potency and a 20-30 minute window of action.

Dose
50–150 mcg
Frequency
Once daily
Half-life
24 min
Animal only
Growth Factors

Long R3 IGF-1 · LR3 IGF-1

Modified IGF-1 that evades its binding proteins, making it far more potent than the native hormone.

Dose
20–80 mcg
Frequency
Once daily
Half-life
Animal only
Secretagogues

NNC 26-0161 · Ipam

The selective GHRP: a clean GH pulse with almost no cortisol, prolactin or hunger.

Dose
100–400 mcg
Frequency
1-3x daily
Half-life
2 h
Early human
HPTA

KP-10 · Kp-10

Upstream GnRH trigger — the switch that makes the hypothalamus fire and the pituitary release LH.

Dose
10–100 mcg
Frequency
3x weekly on non-consecutive days
Half-life
4 min
Early human
Healing

Lys-Pro-Val · alpha-MSH (11-13)

Tripeptide tail of alpha-MSH used to damp gut and skin inflammation.

Dose
250–1000 mcg
Frequency
1x daily
Half-life
Animal only
Fat Loss

Lira · Victoza

Daily first-generation GLP-1 agonist; weaker and more injection-heavy than the weekly analogues.

Dose
0.6–3 mg
Frequency
Once daily
Half-life
13 h
Human trials
Immune

Cathelicidin LL-37 · hCAP-18/LL-37

The only human cathelicidin: broad antimicrobial and biofilm-disrupting innate immune peptide.

Dose
100–500 mcg
Frequency
once daily
Half-life
Early human
Sexual Health

MT-1 · MT-I

Tanning-focused melanocortin agonist — the pigment of MT-II with far less nausea or erections.

Dose
250–1000 mcg
Frequency
Daily during the 10-14 day loading phase, then 1-2x weekly for maintenance
Half-life
1 h
Human trials
Sexual Health

MT-2 · MT-II

Non-selective melanocortin agonist for deep tanning, with libido and nausea along for the ride.

Dose
100–1000 mcg
Frequency
Daily during the loading phase, then 1-2x weekly for maintenance
Half-life
Early human
Secretagogues

Ibutamoren mesylate · MK-0677

Oral ghrelin mimetic that raises GH and IGF-1 for a full 24 hours from one daily dose.

Dose
5–25 mg
Frequency
Once daily
Half-life
6 h
Human trials
Longevity

MOTSc · Mitochondrial-derived peptide MOTS-c

Mitochondrial-encoded peptide studied for insulin sensitivity and exercise capacity.

Dose
2.5–10 mg
Frequency
3x per week
Half-life
Animal only
Growth Factors

Pegylated MGF · MGF

PEGylated IGF-1Ec E-peptide used after training to extend satellite-cell signalling.

Dose
100–400 mcg
Frequency
2x weekly
Half-life
Animal only
Sexual Health

Bremelanotide · Vyleesi

Melanocortin agonist that works on desire in the brain rather than blood flow in the penis.

Dose
0.5–2 mg
Frequency
As needed, no more than once in 24 hours and no more than 8 doses per month
Half-life
2.7 h
Human trials
Fat Loss

Reta · LY3437943

Investigational weekly triple GIP/GLP-1/glucagon agonist with the largest weight loss seen yet.

Dose
1–12 mg
Frequency
Once weekly
Half-life
6 days
Human trials
Neuro

TP-7 · Selank 0.15%

Russian anxiolytic heptapeptide used for anxiety without benzo sedation or dependence.

Dose
150–900 mcg
Frequency
2x daily (Russian trials used 3x daily)
Half-life
Early human
Fat Loss

Sema · Ozempic

Long-acting GLP-1 agonist dosed weekly; the reference compound for appetite-driven fat loss.

Dose
0.25–2.4 mg
Frequency
Once weekly
Half-life
7 days
Human trials
Neuro

MEHFPGP · ACTH(4-7)-Pro-Gly-Pro

Russian ACTH-fragment peptide dosed intranasally for focus, drive and neuroprotection.

Dose
200–600 mcg
Frequency
Once daily, occasionally split AM and early afternoon
Half-life
Early human
Secretagogues

GRF 1-29 · GHRH (1-29)

The first 29 amino acids of human GHRH, once approved as Geref and now compounded.

Dose
100–500 mcg
Frequency
once nightly, 5-7 nights per week
Half-life
12 min
Human trials
Longevity

Elamipretide · MTP-131

Cardiolipin-binding mitochondrial peptide, FDA-approved as elamipretide for Barth syndrome.

Dose
5–40 mg
Frequency
Once daily
Half-life
2 h
Human trials
Fat Loss

BI 456906 · BI-456906

Weekly glucagon/GLP-1 dual agonist that raises energy expenditure as well as cutting appetite.

Dose
0.3–6 mg
Frequency
once weekly
Half-life
6 days
Human trials
Healing

Thymosin β4 · Tβ4

Actin-regulating thymosin peptide used for soft-tissue repair and range of motion.

Dose
2–5 mg
Frequency
2x weekly during loading, then once every 1-2 weeks for maintenance
Half-life
2 h
Early human
Secretagogues

Egrifta · EGRIFTA SV

The only FDA-approved GHRH analogue, proven to shrink visceral abdominal fat.

Dose
1–2 mg
Frequency
once daily
Half-life
8 min
Human trials
Immune

Ta1 · TA-1

Thymic peptide that tunes T-cell function; licensed abroad as thymalfasin for hepatitis B.

Dose
800–1600 mcg
Frequency
2x weekly, spaced 3-4 days apart
Half-life
2 h
Human trials
Immune

FTS · Serum thymic factor

Zinc-dependent thymic nonapeptide studied for T-cell maturation and inflammatory pain.

Dose
100–500 mcg
Frequency
once daily
Half-life
Early human
Fat Loss

Tirz · Mounjaro

Weekly dual GIP/GLP-1 agonist; beats semaglutide on total weight loss in head-to-head data.

Dose
2.5–15 mg
Frequency
Once weekly
Half-life
4.9 days
Human trials
HPTA

Trelstar · Decapeptyl

Long-acting GnRH agonist taken as one microdose to fire off a large LH and FSH surge.

Dose
50–100 mcg
Frequency
Single one-off dose
Half-life
2.8 h
Human trials

Browse by class